Responses of Cancer Cells With Wild-Type or Tyrosine Kinase Domain-Mutated Epidermal Growth Factor Receptor (EGFR) to EGFR-targeted Therapy Are Linked to Downregulation of Hypoxia-Inducible Factor-1α

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-6-63
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search